Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Differential expression of several drug transporter genes in HepG2 and Huh-7 cell lines.

Louisa M, Suyatna FD, Wanandi SI, Asih PB, Syafruddin D.

Adv Biomed Res. 2016 Jun 8;5:104. doi: 10.4103/2277-9175.183664. eCollection 2016.

2.

Copper regulates cyclic-AMP-dependent lipolysis.

Krishnamoorthy L, Cotruvo JA Jr, Chan J, Kaluarachchi H, Muchenditsi A, Pendyala VS, Jia S, Aron AT, Ackerman CM, Wal MN, Guan T, Smaga LP, Farhi SL, New EJ, Lutsenko S, Chang CJ.

Nat Chem Biol. 2016 Aug;12(8):586-92. doi: 10.1038/nchembio.2098. Epub 2016 Jun 6.

PMID:
27272565
3.

The Role of PDE3B Phosphorylation in the Inhibition of Lipolysis by Insulin.

DiPilato LM, Ahmad F, Harms M, Seale P, Manganiello V, Birnbaum MJ.

Mol Cell Biol. 2015 Aug;35(16):2752-60. doi: 10.1128/MCB.00422-15. Epub 2015 Jun 1.

4.

Targeted disruption of PDE3B, but not PDE3A, protects murine heart from ischemia/reperfusion injury.

Chung YW, Lagranha C, Chen Y, Sun J, Tong G, Hockman SC, Ahmad F, Esfahani SG, Bae DH, Polidovitch N, Wu J, Rhee DK, Lee BS, Gucek M, Daniels MP, Brantner CA, Backx PH, Murphy E, Manganiello VC.

Proc Natl Acad Sci U S A. 2015 Apr 28;112(17):E2253-62. doi: 10.1073/pnas.1416230112. Epub 2015 Apr 15.

5.

The role of mouse Akt2 in insulin-dependent suppression of adipocyte lipolysis in vivo.

Koren S, DiPilato LM, Emmett MJ, Shearin AL, Chu Q, Monks B, Birnbaum MJ.

Diabetologia. 2015 May;58(5):1063-70. doi: 10.1007/s00125-015-3532-9. Epub 2015 Mar 5.

6.

Selective insulin resistance in adipocytes.

Tan SX, Fisher-Wellman KH, Fazakerley DJ, Ng Y, Pant H, Li J, Meoli CC, Coster AC, Stöckli J, James DE.

J Biol Chem. 2015 May 1;290(18):11337-48. doi: 10.1074/jbc.M114.623686. Epub 2015 Feb 26.

7.

Regulation of sarcoplasmic reticulum Ca2+ ATPase 2 (SERCA2) activity by phosphodiesterase 3A (PDE3A) in human myocardium: phosphorylation-dependent interaction of PDE3A1 with SERCA2.

Ahmad F, Shen W, Vandeput F, Szabo-Fresnais N, Krall J, Degerman E, Goetz F, Klussmann E, Movsesian M, Manganiello V.

J Biol Chem. 2015 Mar 13;290(11):6763-76. doi: 10.1074/jbc.M115.638585. Epub 2015 Jan 15.

8.

Age-related differences in phosphodiesterase activity and effects of chronic phosphodiesterase inhibition in idiopathic dilated cardiomyopathy.

Nakano SJ, Miyamoto SD, Movsesian M, Nelson P, Stauffer BL, Sucharov CC.

Circ Heart Fail. 2015 Jan;8(1):57-63. doi: 10.1161/CIRCHEARTFAILURE.114.001218. Epub 2014 Oct 2.

9.

Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets.

Ahmad F, Murata T, Shimizu K, Degerman E, Maurice D, Manganiello V.

Oral Dis. 2015 Jan;21(1):e25-50. doi: 10.1111/odi.12275. Epub 2014 Sep 12.

10.

Advances in targeting cyclic nucleotide phosphodiesterases.

Maurice DH, Ke H, Ahmad F, Wang Y, Chung J, Manganiello VC.

Nat Rev Drug Discov. 2014 Apr;13(4):290-314. doi: 10.1038/nrd4228. Review.

11.

Selective regulation of cyclic nucleotide phosphodiesterase PDE3A isoforms.

Vandeput F, Szabo-Fresnais N, Ahmad F, Kho C, Lee A, Krall J, Dunlop A, Hazel MW, Wohlschlegel JA, Hajjar RJ, Houslay MD, Manganiello VC, Movsesian MA.

Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):19778-83. doi: 10.1073/pnas.1305427110. Epub 2013 Nov 18.

12.

From PDE3B to the regulation of energy homeostasis.

Degerman E, Ahmad F, Chung YW, Guirguis E, Omar B, Stenson L, Manganiello V.

Curr Opin Pharmacol. 2011 Dec;11(6):676-82. doi: 10.1016/j.coph.2011.09.015. Epub 2011 Oct 14. Review.

13.

Insulin contributes to fine-tuning of the pancreatic beta-cell response to glucagon-like peptide-1.

Moon MJ, Kim HY, Park S, Kim DK, Cho EB, Hwang JI, Seong JY.

Mol Cells. 2011 Oct;32(4):389-95. doi: 10.1007/s10059-011-0157-9. Epub 2011 Sep 7.

14.

Insulin regulates adipocyte lipolysis via an Akt-independent signaling pathway.

Choi SM, Tucker DF, Gross DN, Easton RM, DiPilato LM, Dean AS, Monks BR, Birnbaum MJ.

Mol Cell Biol. 2010 Nov;30(21):5009-20. doi: 10.1128/MCB.00797-10. Epub 2010 Aug 23.

15.

Regulation of cAMP by phosphodiesterases in erythrocytes.

Adderley SP, Sprague RS, Stephenson AH, Hanson MS.

Pharmacol Rep. 2010 May-Jun;62(3):475-82. Review.

16.

The biological activity of structurally defined inositol glycans.

Goel M, Azev VN, d'Alarcao M.

Future Med Chem. 2009 Apr;1(1):95-118.

17.

Differential regulation of adipocyte PDE3B in distinct membrane compartments by insulin and the beta3-adrenergic receptor agonist CL316243: effects of caveolin-1 knockdown on formation/maintenance of macromolecular signalling complexes.

Ahmad F, Lindh R, Tang Y, Ruishalme I, Ost A, Sahachartsiri B, Strålfors P, Degerman E, Manganiello VC.

Biochem J. 2009 Dec 10;424(3):399-410. doi: 10.1042/BJ20090842.

18.

Interaction of phosphodiesterase 3A with brefeldin A-inhibited guanine nucleotide-exchange proteins BIG1 and BIG2 and effect on ARF1 activity.

Puxeddu E, Uhart M, Li CC, Ahmad F, Pacheco-Rodriguez G, Manganiello VC, Moss J, Vaughan M.

Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6158-63. doi: 10.1073/pnas.0901558106. Epub 2009 Mar 30.

19.

Phosphodiesterase 3B is localized in caveolae and smooth ER in mouse hepatocytes and is important in the regulation of glucose and lipid metabolism.

Berger K, Lindh R, Wierup N, Zmuda-Trzebiatowska E, Lindqvist A, Manganiello VC, Degerman E.

PLoS One. 2009;4(3):e4671. doi: 10.1371/journal.pone.0004671. Epub 2009 Mar 5.

20.

Protein kinase C-mediated phosphorylation and activation of PDE3A regulate cAMP levels in human platelets.

Hunter RW, Mackintosh C, Hers I.

J Biol Chem. 2009 May 1;284(18):12339-48. doi: 10.1074/jbc.M807536200. Epub 2009 Mar 4.

Items per page

Supplemental Content

Write to the Help Desk